• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nifedipine does not adversely affect uteroplacental blood flow in the hypertensive term-pregnant rat.

作者信息

Ahokas R A, Sibai B M, Mabie W C, Anderson G D

机构信息

Department of Obstetrics and Gynecology, University of Tennessee, Memphis 38163.

出版信息

Am J Obstet Gynecol. 1988 Dec;159(6):1440-5. doi: 10.1016/0002-9378(88)90571-6.

DOI:10.1016/0002-9378(88)90571-6
PMID:3207122
Abstract

The short-term effect of the calcium channel blocker, nifedipine, on maternal hemodynamics and organ perfusion was investigated in 12 hypertensive term-pregnant, spontaneously hypertensive rats by means of the radioactive-labeled microsphere technique. The normal fall in blood pressure during pregnancy was prevented by reducing litter size to two conceptuses on day 7 of gestation. Nifedipine (200 micrograms/kg) effectively lowered mean arterial pressure 25% by decreasing total peripheral resistance 38%. Cardiac output was increased 15%. Blood flows to the splanchnic region and the reproductive organs were increased after nifedipine administration. The increase in blood flow to the reproductive organs was the result of increased ovarian and uterine wall perfusion caused by large reductions in vascular resistances. Placental blood flow was not significantly altered, but resistance was decreased. Thus, the use of nifedipine to lower maternal blood pressure in pregnancy complicated by extreme hypertension does not necessarily decrease uteroplacental perfusion.

摘要

相似文献

1
Nifedipine does not adversely affect uteroplacental blood flow in the hypertensive term-pregnant rat.
Am J Obstet Gynecol. 1988 Dec;159(6):1440-5. doi: 10.1016/0002-9378(88)90571-6.
2
Maternal and uteroplacental hemodynamic effects of chronic captopril in the hypertensive, term-pregnant rat.
Am J Obstet Gynecol. 1990 Dec;163(6 Pt 1):1861-7. doi: 10.1016/0002-9378(90)90765-y.
3
Labetalol does not decrease placental perfusion in the hypertensive term-pregnant rat.
Am J Obstet Gynecol. 1989 Feb;160(2):480-4. doi: 10.1016/0002-9378(89)90476-6.
4
Uteroplacental blood flow in the hypertensive, term pregnant, spontaneously hypertensive rat.
Am J Obstet Gynecol. 1987 Apr;156(4):1010-5. doi: 10.1016/0002-9378(87)90378-4.
5
The acute effects of a non-selective beta-adrenergic blocking agent in hypertensive pregnant rats.非选择性β-肾上腺素能阻滞剂对高血压妊娠大鼠的急性影响。
Acta Obstet Gynecol Scand Suppl. 1984;118:81-4. doi: 10.3109/00016348409157129.
6
Acute haemodynamic effects of pindolol during pregnancy in experimental renal hypertension.吲哚洛尔在妊娠实验性肾性高血压期间的急性血流动力学效应
Acta Obstet Gynecol Scand Suppl. 1984;118:85-90. doi: 10.3109/00016348409157130.
7
The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy.舌下含服硝苯地平对妊娠高血压患者子宫胎盘血流的影响。
Br J Obstet Gynaecol. 1988 Dec;95(12):1276-81. doi: 10.1111/j.1471-0528.1988.tb06818.x.
8
Effect of K+ATP channel inhibition on total and regional vascular resistance in guinea pig pregnancy.钾离子ATP通道抑制对豚鼠妊娠时总血管阻力和局部血管阻力的影响。
Am J Physiol. 1998 Aug;275(2):H680-8. doi: 10.1152/ajpheart.1998.275.2.H680.
9
Uteroplacental hemodynamic response to antihypertensive drugs in hypertensive pregnant sheep.
Perspect Nephrol Hypertens. 1976;5:363-75.
10
Selective increase in placental blood flow by atrial natriuretic peptide in hypertensive rats.
Am J Obstet Gynecol. 1989 Feb;160(2):477-9. doi: 10.1016/0002-9378(89)90475-4.

引用本文的文献

1
Abnormal uterine artery remodelling in the stroke prone spontaneously hypertensive rat.易中风自发性高血压大鼠子宫动脉的异常重塑
Placenta. 2016 Jan;37:34-44. doi: 10.1016/j.placenta.2015.10.022. Epub 2015 Nov 10.
2
Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.
Drug Saf. 1992 May-Jun;7(3):223-34. doi: 10.2165/00002018-199207030-00007.